Pss53 - Originator and Generic Market Access Protection Strategies in Germany Using Dermatology as an Example

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2553
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Establish Halal Market Access, New Zealand an Example

Social Sciences
2017English

PHP16 Generic Drug Market Access in Japan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Research on B2C E-Commerce Marketing Strategies Using Jingdong Mall as an Example

2017English

Media Market as an Example of a Deregulated Market: Historical and Social Analysis of the Local Media

European Journal of Sustainable Development
2019English

An Exploration in Mineral Supply Chain Mapping Using Tantalum as an Example

Open-File Report
2013English

Discrepancies Between the Labels of Originator and Generic Pharmaceutical Products: Implications for Patient Safety

Drugs - Real World Outcomes
Pharmacology
2020English

Strategies of Protection of Intellectual Property as an Intangible Regulatory Asset of an Organization

International Journal of Contemporary Management
2017English

Pdb91 - Explaining the Disparities of Market Access for Gliflozins in France, Spain, Germany and the United-Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Embodiment of Tacit Knowledge as an Insrument of Competitive Strength in the Cultural Market: An Example of Antakya

Pressacademia
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy